JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thakur, M. L.
Right arrow Articles by Alavi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thakur, M. L.
Right arrow Articles by Alavi, A.

PET Imaging of Oncogene Overexpression Using 64Cu-Vasoactive Intestinal Peptide (VIP) Analog: Comparison with 99mTc-VIP Analog

Mathew L. Thakur, PhD1,2, Mohan R. Aruva, PhD1,2, Jean Gariepy, MD3, Paul Acton, PhD4, Satish Rattan, MD5, Shyam Prasad, PhD1,2, Eric Wickstrom, PhD2,6 and Abass Alavi, MD4

1 Department of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania
2 Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania
3 Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
4 Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania
5 Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
6 Department of Biochemistry and Molecular Pharmacology, Thomas Jefferson University, Philadelphia, Pennsylvania



View larger version (14K):

[in a new window]
 
FIGURE 1. Schematic presentation of TP3982.

 


View larger version (22K):

[in a new window]
 
FIGURE 2. Effect of increasing concentration of VIP28, unlabeled TP3654, and unlabeled TP3982, on resting opossum IAS smooth muscle tissue. At 1 x 10–6 mol/L TP3654 and TP3982, ~95% relaxivity was achieved with ~75% for VIP28 at the same concentration. Data suggest that biologic activity of TP3982 was not compromised.

 


View larger version (19K):

[in a new window]
 
FIGURE 3. SELDI-TOF-mass spectrum of Cu-TP3982 complex, depicting the complex mass of 4,049.7 Da and the mass of unreacted TP3982 at 3,982.7 Da.

 


View larger version (17K):

[in a new window]
 
FIGURE 4. HPLC elution profile of 64Cu-TP3982. 100% radioactivity was eluted in a single peak at Rt 8 min. Unbound 64Cu elutes at Rt 4.2 min. The diagonal line is percent solvent B (B = 0.1% TFA/ACN; A = 0.1% TFA/H2O).

 


View larger version (32K):

[in a new window]
 
FIGURE 5. Composite of 3 representative 24-h images of T47D human BC bearing nude mice receiving 99mTc-TP3654 (left), 99mTc-TP3982 (center), and 64Cu-TP3982 (right). The gray scale in the first 2 {gamma}-camera images was 0 to 50. The 1-mm coronal PET image of a mouse given 64Cu-TP3982 shows enhanced uptake in the tumor. {gamma}-Camera images are in posterior position. Tumor is in right flank in each mouse.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.